Skip to main content
Advertisement
Advertisement
SNY
SNY logo
Sanofi - ADR
47.47
USD
Sponsored
+2.14
+4.72%
Nov 04, 15:59 UTC -5
Closed
exchange

After-Market

47.06

-0.41
-0.86%

Sanofi - ADR (SNY) Earnings

SNY Earnings Reports

Positive Surprise Ratio

SNY beat 33 of 43 last estimates.

77%

Next Report

Date of Next Report
Jan 27, 2027
Estimate for Q4 26 (Revenue/ EPS)
$13.19B
/
$1.88
Implied change from Q3 26 (Revenue/ EPS)
-11.16%
/
+3.30%
Implied change from Q4 25 (Revenue/ EPS)
+16.66%
/
+22.88%

Sanofi - ADR earnings per share and revenue

On Oct 30, 2026, SNY reported earnings of 1.82 USD per share (EPS) for Q3 26, missing the estimate of 2.80 USD, resulting in a -35.08% surprise. Revenue reached 14.84 billion, compared to an expected 13.65 billion, with a 8.74% difference. The market reacted with a +2.81% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 1.88 USD, with revenue projected to reach 13.19 billion USD, implying an increase of 3.30% EPS, and decrease of -11.16% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Pfizer Inc.
Report Date
Nov 03, 2026 For Q3 26
Estimate
$0.73
Actual
$0.87
Surprise
+18.76%
logo
Eli Lilly & Co.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$6.32
Actual
$7.48
Surprise
+18.32%
logo
ABBVIE INC.
Report Date
Oct 30, 2026 For Q3 26
Estimate
$3.82
Actual
$3.82
Surprise
-0.08%
logo
Merck & Co., Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$2.10
Actual
$2.49
Surprise
+18.46%
logo
Novartis AG
Report Date
Oct 27, 2026 For Q3 26
Estimate
$2.33
Actual
$2.46
Surprise
+5.50%
FAQ
For Q3 2026, Sanofi - ADR reported EPS of $1.82, missing estimates by -35.08%, and revenue of $14.84B, 8.74% above expectations.
The stock price moved up 2.81%, changed from $43.13 before the earnings release to $44.34 the day after.
The next earning report is scheduled for Jan 27, 2027.
Based on -- analysts, Sanofi - ADR is expected to report EPS of $1.88 and revenue of $13.19B for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement